A Study Explore JS001+JS002 in Patients With Advanced Cancer

Clinical trial NCT05128539 · TERMINATED

Trial details

NCT number: NCT05128539
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2022-02-10
Primary completion: 2023-11-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.